Impact Biomedical Share Price Today: Live Updates & Key Insights

Impact Biomedical share price today is $0.78, up 68.47%. The stock opened at $0.4575 against the previous close of $0.463, with an intraday high of $0.78 and low of $0.4211.

Impact Biomedical Share Price Chart

Impact Biomedical

us-stock
To Invest in {{usstockname}}
us-stock

Impact Biomedical Share Price Performance

$0.78 0.6847(68.47%) IBO at 23 Mar 2026 01:33 PM Biotechnology
Lowest Today 0.4211
Highest Today 0.78
Today’s Open 0.4575
Prev. Close 0.463
52 Week High 4.50
52 Week Low 0.36
Day’s Range: Low 0.4211 High 0.78
52-Week Range: Low 0.36 High 4.50
1 day return -
1 Week return +55.53
1 month return +56.38
3 month return +24.03
6 month return +4.05
1 year return -81.99
3 year return -
5 year return -
10 year return -

Impact Biomedical Institutional Holdings

Impact Biomedical Market Status

Impact Biomedical Fundamentals

Market Cap 84.10 M

PB Ratio 3.9592

PE Ratio 0.0

Enterprise Value 72.85 M

Total Assets 17.41 M

Volume 7372690

Impact Biomedical Company Financials

About Impact Biomedical & investment objective

Company Information Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. It also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, the company develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use as health supplements and medications. Further, it is developing 3F (functional fragrance formulation), a formulation of botanical ingredients. Impact BioMedical Inc. was incorporated in 2018 and is based in Houston, Texas. Impact BioMedical Inc. operates as a subsidiary of DSS BioHealth Security, Inc

Organisation Biotechnology

Employees 2

Industry Biotechnology

CEO Mr. Frank D. Heuszel Esq., J.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Impact Biomedical FAQs

What is the share price of Impact Biomedical today?

The current share price of Impact Biomedical is $0.78.

Can I buy Impact Biomedical shares in India?

Yes, Indian investors can buy Impact Biomedical shares by opening an international trading and demat account with Motilal Oswal.

How to buy Impact Biomedical shares in India?

You can easily invest in Impact Biomedical shares from India by:

Can I buy fractional shares of Impact Biomedical?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Impact Biomedical?

Impact Biomedical has a market cap of $84.10 M.

In which sector does Impact Biomedical belong?

Impact Biomedical operates in the Biotechnology sector.

What documents are required to invest in Impact Biomedical stocks?

To invest, you typically need:

What is the PE and PB ratio of Impact Biomedical?

The PE ratio of Impact Biomedical is N/A and the PB ratio is 3.96.